CRISPRed crops and agbiotech’s future
In this issue:
- Bioeconomy: Uncertainty about review of EU strategy hampers investments
- Orphan Drugs: How can healthcare systems establish value-based pricing?
- Allergies New biotech solutions target oversensitive immune systems
- Biofairs Compass: Your guide to relevant EU life sciences events in H2/2017
- Focus Biomanufacturing: Bright future for biomanufacturers
- Interviews with Federico Pollano, Business Development & Contract Manufacturing Director, Polpharma and Daniel Oliver, CEO, Capital Cell, Barcelona
- News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association
Industry criticises EPO plans
Concerns raised by life sciences stakeholders regarding the European Patent Office’s Early Certainty in Examination project can no longer be...
Microfluidics: Mapping DNA-binders
A patent on microfluidics-based ligand enrichment followed by sequencing has been filed, and the group, headed by Bart Deplancke, aims to...
A clear path ahead for the bioeconomy
European Biotechnology Matti, you say we need to stop using fossil fuels. But right now there hardly seems to be a consensus on that –...